Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
30 hedge funds and large institutions have $5.77M invested in Sophiris Bio, Inc. in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
3% more funds holding
Funds holding: 29 → 30 (+1)
0% more capital invested
Capital invested by funds: $5.76M → $5.77M (+$17.9K)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
94% less call options, than puts
Call options by funds: $1K | Put options by funds: $18K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$496K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$330K |
| 3 |
Squarepoint
New York
|
+$251K |
| 4 |
LWAC
Laurel Wealth Advisors (California)
Solana Beach,
California
|
+$28.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$15.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$737K |
| 2 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
-$79.4K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$55.5K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$41K |
| 5 |
Millennium Management
New York
|
-$32.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $5K | – | – | – |
|
|
FANJ
27
Financial Architects (New Jersey)
Marlton,
New Jersey
| $1K | – | – | – |
|
|
JCM
28
Jacobi Capital Management
Pittston,
Pennsylvania
| $1K | – | – | – |
|
|
ARTA
29
A.R.T. Advisors
New York
| – | -$41K | -13,200 | Closed |
|
|
BCM
30
Bourgeon Capital Management
Darien,
Connecticut
| – | -$31K | -10,000 | Closed |
|
|
FMA
31
FNY Managed Accounts
New York
| – | -$26.1K | -8,400 | Closed |
|
32
Walleye Trading
New York
| – | -$6K | -1,800 | Closed |
|
33
Simplex Trading
Chicago,
Illinois
| – | +$283 | +100 | New |
|
SPHS Hedge Fund Activity: Q4 2016 in Review
30 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q4 2016, worth a combined $5.77M — up 0.31% from $5.76M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SPHS positions and 4 closed out — a net gain of 1 holder — while 7 added to existing stakes and 8 trimmed.
The largest buyer was Oxford Asset Management, opening a new position worth an estimated $496K. The largest seller was Sabby Management, cutting an estimated $737K.
- 30 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q4 2016, up from 29 in Q3 2016.
- Funds reported $5.77M of Sophiris Bio, Inc. stock for Q4 2016, up 0.31% quarter-over-quarter.
- 5 funds opened new Sophiris Bio, Inc. positions in Q4 2016 and 4 closed out, a net change of +1 holder.
- The largest Sophiris Bio, Inc. buyer in Q4 2016 was Oxford Asset Management, an estimated $496K added.
- The largest Sophiris Bio, Inc. seller in Q4 2016 was Sabby Management, an estimated $737K sold.
Based on aggregated 13F filings for Q4 2016.